These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9308074)
1. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine. Bertschy G; Bryois C; Bondolfi G; Velardi A; Budry P; Dascal D; Martinet C; Baettig D; Baumann P Pharmacol Res; 1997 May; 35(5):451-6. PubMed ID: 9308074 [TBL] [Abstract][Full Text] [Related]
2. Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin. Zullino DF; Krenz S; Zimmerman G; Miozzari A; Rajeswaran R; Kolly S; Khazaal Y Subst Abus; 2004 Dec; 25(4):27-33. PubMed ID: 16172090 [TBL] [Abstract][Full Text] [Related]
3. The efficiency of a carbamazepine-mianserin combination scheme in opiate detoxification. Zullino DF; Krenz S; Favrat B; Zimmermann G; Bertschy G; Besson J Hum Psychopharmacol; 2004 Aug; 19(6):425-30. PubMed ID: 15303247 [TBL] [Abstract][Full Text] [Related]
4. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study. Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843 [TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826 [TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961 [TBL] [Abstract][Full Text] [Related]
8. Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. Nair V; Mahadevan S J Trop Pediatr; 2009 Apr; 55(2):116-21. PubMed ID: 19203986 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine in opiate withdrawal: a comparison with clonidine. Nigam AK; Ray R; Tripathi BM J Subst Abuse Treat; 1993; 10(4):391-4. PubMed ID: 8257551 [TBL] [Abstract][Full Text] [Related]
10. Comparison of acetorphan with clonidine for opiate withdrawal symptoms. Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165 [TBL] [Abstract][Full Text] [Related]
11. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296 [TBL] [Abstract][Full Text] [Related]
12. A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms. Shi J; Xu GZ; Liu TT; Wang X; Shen LY; Li J; Hao W; Chen HX; Li SX; Lu L Am J Drug Alcohol Abuse; 2008; 34(6):792-800. PubMed ID: 19016185 [TBL] [Abstract][Full Text] [Related]
13. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Gold MS; Redmond DE; Kleber HD Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997 [No Abstract] [Full Text] [Related]
14. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Malcolm R; Ballenger JC; Sturgis ET; Anton R Am J Psychiatry; 1989 May; 146(5):617-21. PubMed ID: 2653057 [TBL] [Abstract][Full Text] [Related]
15. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal. Akhondzadeh S; Ahmadi-Abhari SA; Assadi SM; Shabestari OL; Kashani AR; Farzanehgan ZM J Clin Pharm Ther; 2000 Oct; 25(5):347-53. PubMed ID: 11123486 [TBL] [Abstract][Full Text] [Related]
16. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208 [TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615 [TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302 [TBL] [Abstract][Full Text] [Related]
19. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients. Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291 [TBL] [Abstract][Full Text] [Related]
20. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients]. Sós I; Kiss N; Csorba J; Gerevich J Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]